04.17.2020
Webinar: Finding Solutions for public health threats: COVID-19
What are innovators doing to speed up the path to treating and preventing COVID-19?
The novel coronavirus has quickly taken...
News & Insights
Emergent CDMO News, Insights & Events
When a company develops, manufactures and delivers vaccines and therapeutics that take on the most serious global health threats, it’s not surprising to see their name in the headlines. And we are honored that for more than 20 years, Emergent has been one of those names. Included below are prominent news and feature stories that profile a range of our accomplishments through the years as well as advancements we’ve made in the technologies, processes and expertise needed to serve as a premier CDMO.
04.01.2020
Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™
- CDMO agreement for NanoFlu to support pathway to licensure
- Expanded collaboration now includes NanoFlu and COVID-19 vaccine...
03.23.2020
Novavax + Emergent: In the news
Original news coverage of Novavax's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...
03.23.2020
Vaxart + Emergent: In the news
Original news coverage of Vaxart's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...
03.19.2020
Vaxart AGREEMENT for Experimental Oral Vaccine Candidate for Coronavirus Disease
GAITHERSBURG, Md., March 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered...
03.19.2020
Novavax agreement for Experimental Vaccine Candidate for Coronavirus Disease
GAITHERSBURG, Md., March 10, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered...